Skip to content

Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02046980
Enrollment
209
Registered
2014-01-28
Start date
2013-09-30
Completion date
2015-07-31
Last updated
2016-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Paroxysmal Positional Vertigo

Brief summary

To determine the short term therapeutic efficacies of Gufoni maneuver and mastoid oscillation in apogeotropic type of benign paroxysmal positional vertigo (BPPV) involving the horizontal semicircular canal (HC-BPPV), a randomized, prospective, sham-controlled study was conducted.

Detailed description

The apogeotropic type of benign paroxysmal positional vertigo involving the horizontal canal (HC-BPPV) is likely due to otolithic debris in the anterior arm of the canal (canalithiasis) or the debris attached to the cupula (cupulolithiasis). It is important to seek the method to convert treatment-resistant apogeotropic form to the more treatment-responsive geotropic form in HC-BPPV. Recent randomized trials demonstrated that head shaking maneuver was more effective than the modified Semont maneuver and the Gufoni and head shaking maneuvers showed similar efficacy in treating apogeotropic HC-BPPV. Moreover, new repositioning maneuver using mastoid vibration showed good efficacies in patients with apogeotropic HC-BPPV in recent study. So we tried to compare the short term therapeutic efficacies of Gufoni maneuver and mastoid oscillation in apogeotropic HC-BPPV with a randomized, prospective, sham-controlled study.

Interventions

PROCEDUREGufoni
PROCEDUREVibration
PROCEDURESham

Sponsors

Keimyung University Dongsan Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. history of vertigo associated with changes in head position 2. direction-changing horizontal nystagmus beating toward the uppermost ear (apogeotropic nystagmus) in both turning positions detected with Frenzel glasses or videoculography in the Head turning test 3. vertigo associated with the elicited nystagmus 4. symptom within 2 weeks 5. put one's signature on consent

Exclusion criteria

1. patients with identifiable central nervous system disorders that could explain the positional vertigo and nystagmus 2. the patients with apogeotropic form which was transited from geotropic after previous therapeutic maneuvers 3. the patients who transited from apogeotropic from vertical canal BPPV during study 4. patients who had possible cause of secondary BPPV such as Meniere's disease, migraine or recent trauma history 5. patients whose affected ear cannot be identified 6. patients with multiple canal atypical positional nystagmus or who were treated previously with repositioning maneuvers were excluded. 7. patients with cervical or lumbar spine problem

Design outcomes

Primary

MeasureTime frame
Conversion in Direction of Nystagmus From Apogeotropic to Geotropic or Disappearance of Nystagmus2 days

Countries

South Korea

Participant flow

Pre-assignment details

217 patients enrolled in the study but 8 retracted their agreements.

Participants by arm

ArmCount
Gufoni
Gufoni maneuver for apogeotropic horizontal BPPV at the first day Gufoni
70
Vibration
Vibration maneuver for apogeotropic horizontal BPPV at the first day Vibration
67
Sham
Sham maneuver for apogeotropic horizontal BPPV at the first day Sham
72
Total209

Baseline characteristics

CharacteristicGufoniVibrationShamTotal
Age, Continuous62.00 years
STANDARD_DEVIATION 11.58
62.22 years
STANDARD_DEVIATION 13.25
61.44 years
STANDARD_DEVIATION 13.48
61.9 years
STANDARD_DEVIATION 12.7
Lesion side
Left side
29 participants30 participants39 participants98 participants
Lesion side
Right side
41 participants37 participants33 participants111 participants
Sex: Female, Male
Female
42 Participants39 Participants52 Participants133 Participants
Sex: Female, Male
Male
28 Participants28 Participants20 Participants76 Participants
Symptom duration3.37 days2.70 days2.52 days2.9 days

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 720 / 720 / 73
serious
Total, serious adverse events
0 / 720 / 720 / 73

Outcome results

Primary

Conversion in Direction of Nystagmus From Apogeotropic to Geotropic or Disappearance of Nystagmus

Time frame: 2 days

Population: 217 patients enrolled in the study but 8 retracted their agreements.

ArmMeasureValue (NUMBER)
GufoniConversion in Direction of Nystagmus From Apogeotropic to Geotropic or Disappearance of Nystagmus51 participants
VibrationConversion in Direction of Nystagmus From Apogeotropic to Geotropic or Disappearance of Nystagmus46 participants
ShamConversion in Direction of Nystagmus From Apogeotropic to Geotropic or Disappearance of Nystagmus38 participants
p-value: 0.0283995% CI: [1.58, 7.31]Regression, Logistic
p-value: 0.036695% CI: [1.25, 5.67]Regression, Logistic

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026